View
218
Download
0
Embed Size (px)
Citation preview
7/31/2019 Mary Kay Owens - Understanding and Addressing Medicaid Hot Spots Critical for Bending the Cost Curve
1/13
2012S
HI
I
1
Understanding and AddressingHot Spots
Critical Approaches For Bending theMedicaid Cost Curve
Mary Kay Owens, R.Ph., C.Ph.
Executive Director, Institute for Healthcare Innovation Strategies
Associate Professor, University of Florida College of Pharmacy
National Alliance for Integrated Medication Management (AIMM) Exec. Board
May 31, 2012
PFCD Hill Briefing, Washington, DC
7/31/2019 Mary Kay Owens - Understanding and Addressing Medicaid Hot Spots Critical for Bending the Cost Curve
2/13
2012S
HI
I
2
Identifying the Targets:
Hot Spots include Patients with
Uncoordinated Care, Lack of
Appropriate Medication Use, andUnmet Treatment Goals for Chronic
Conditions
7/31/2019 Mary Kay Owens - Understanding and Addressing Medicaid Hot Spots Critical for Bending the Cost Curve
3/13
2012S
HI
I
33
State Medicaid Chronic Disease Treatment
Uncoordinated Care10-30% of pop. & account for 30-50% costs
Low Drug Adherence rates
40-65% for major chronic drug classes
Lack of Treatment for Chronic Conditions
Hundreds of thousands with no drug treatment yetincurred $ hundreds of millions in medical costs forconditions (cholesterol, hypertension, MH)
Clinical Goals Unmet
50-80% of patients are not at clinical goals
7/31/2019 Mary Kay Owens - Understanding and Addressing Medicaid Hot Spots Critical for Bending the Cost Curve
4/13
2012S
HI
I
44
Goals of Intelligent ClaimsAnalysis Model
Use clinically and statistically validated algorithms toidentify subset of patients that exhibit utilizationpatterns consistent with uncoordinated andinappropriate care Hot Spot Patients.
Algorithms based on common indicators such as:uncoordinated care from multiple prescribers/pharmacies,accessing the ER for primary care,avoidable ER and hospitalization visits,duplicative medical and drug services from various providers
random drug changes within therapeutic classes by differentprescribers, drug switchinginconsistent drug usage, treatment gaps and non-adherencelack of appropriate treatments/services based on guidelines
7/31/2019 Mary Kay Owens - Understanding and Addressing Medicaid Hot Spots Critical for Bending the Cost Curve
5/13
2012S
HI
I
55
State Medicaid Examples andStrategies
Identify Uncoordinated Care andCreate Solutions to Improve Quality
and Reduce Unnecessary Costs
7/31/2019 Mary Kay Owens - Understanding and Addressing Medicaid Hot Spots Critical for Bending the Cost Curve
6/13
2012S
HI
I
66
Average Contribution of Cost Components forUncoordinated Care vs. Coordinated Care Patients
$2,001
$5,295
$4,907
$1,669
$1,039
$189
$506$1,340
$714 $287
$222$46
$0
$2,000
$4,000
$6,000
$8,000$10,000
$12,000
$14,000
$16,000
Uncoordinated Care
Patients $15,100
Coordinated Care
Patients $3,116
Lab
Out Pt/Hm HlthER
Pharmacy
Practioner
Hospital
7/31/2019 Mary Kay Owens - Understanding and Addressing Medicaid Hot Spots Critical for Bending the Cost Curve
7/13
2012S
HI
I
77
State Example: Utilization and Cost Summaryfor Uncoordinated Care Medicaid Patients
PercentPatients
PercentPrescription
Costs
PercentPrescriptions
45%46%
10%
Uncoordinated Care Utilization and Cost Percentages
32%
PercentMedicalCosts
36%
PercentAll Costs
(drug + medical)
Approx 35% of red bar
costs are avoidable
$1.8B
7/31/2019 Mary Kay Owens - Understanding and Addressing Medicaid Hot Spots Critical for Bending the Cost Curve
8/13
2012S
HI
I
888
State Example: Pre-Medicare Duals Population(Ages 55-64 pop. group)
PercentPatients
PercentPrescription
Costs
PercentPrescriptions
70%71%
28%
Uncoordinated Care Utilization and Cost Percentages
44%
PercentMedicalCosts
52%
PercentAll Costs
(drug + medical)
Approx 35% of red barcosts are avoidable
7/31/2019 Mary Kay Owens - Understanding and Addressing Medicaid Hot Spots Critical for Bending the Cost Curve
9/13
2012S
HI
I
9
Comparison of Uncoordinated Care vs. Coordinated Care Patients
by Cost Groups (Percentage and Amount of Total Costs)
State Example:
Savings Across All Patient Cost Groups(Low to High)
$500-
$999
$1,000-
$4,999
$5,000-
$9,999
$10,000-
$19,999
$20,000-
$29,999
$30,000-
$49,999
$50,000-
$99,999
$100,000
TotalDollarA
mount
$74 M
Total Cost Groups (Annual Medical and Drug Costs)
$19 M
$130 M
$82 M
47%
53%
$61 M
$97 M
$87 M
$123 M
58%
42%
59%
41%
57%
43%
58%
42%
69%
31%10%97%3%
90%
Uncoordinated Care Patients
Coordinated Care Patients
Approx 35% of red bar
costs are avoidable
7/31/2019 Mary Kay Owens - Understanding and Addressing Medicaid Hot Spots Critical for Bending the Cost Curve
10/13
2012S
HI
I
SEC Published Study: Institute of Medicine *National Cost Savings Estimates
Public Programs (Medicaid and Medicare)Avg. of $133.5 billion per year
Private Programs
Avg. of $106.6 billion per yearTotal Public and Private
Avg. of $240.1 billion per year
*Web Link: The Healthcare Imperative: Lowering Costs and Improving Outcomes.The Institute of Medicine. 2010. Washington, DC: The National Academies Press.Owens, MK.Chapter 3: Inefficiently Delivered Services, Costs of Uncoordinated Care,pgs 131-138. http://books.nap.edu/openbook.php?record_id=12750&page=131
http://books.nap.edu/openbook.php?record_id=12750&page=131http://books.nap.edu/openbook.php?record_id=12750&page=1317/31/2019 Mary Kay Owens - Understanding and Addressing Medicaid Hot Spots Critical for Bending the Cost Curve
11/13
2012S
HI
I11
Creating the Path to Success:Utility of New Analytical Approach to
Identify and Address Hot Spots
For Achieving Savings
7/31/2019 Mary Kay Owens - Understanding and Addressing Medicaid Hot Spots Critical for Bending the Cost Curve
12/13
2012S
HI
I
What are the solutions?1. Conduct baseline and periodic analysis of claims
data to identify the Hot Spots - subset of patients totarget that have high risk and uncoordinated care.
2. Conduct geographical mapping of these patients totarget specific areas and providers.
3. Focus intensive efforts in utilization managementand coordination on the targeted patients andproviders.
4. Create hybrid FFS payment models with incentive forsavings and improved outcomes.
5. Implement comprehensive medication managementin targeted patients to achieve appropriate use &adherence to medications. (AIMM Model)
12
7/31/2019 Mary Kay Owens - Understanding and Addressing Medicaid Hot Spots Critical for Bending the Cost Curve
13/13
2012S
HI
I1313
Contact Information
Mary Kay Owens, R.Ph., C.Ph.Executive Director, Institute for Healthcare Innovation Strategies
National Alliance for Integrated Medication Management (AIMM) Board
3019 N. Shannon Lakes Dr., Suite 202Tallahassee, Florida 32309
(850) 668-8524
www.ihis-health.org
mailto:[email protected]://www.sec-rx.com/http://www.sec-rx.com/http://www.sec-rx.com/http://www.sec-rx.com/mailto:[email protected]:[email protected]:[email protected]